Tag: neoadjuvant treatment

Living Longer: Early Stage/ Resectable Pancreatic Cancer

Living Longer: Early Stage/ Resectable Pancreatic Cancer

At diagnosis, less than 20% patients with pancreatic cancer can be resected due to late presentations and advance nature of the disease. However, even in early stages and resectable pancreatic cancer, the average survival is between 15 months - 24 months. Standard of care was for immediate surgical resection if tumor is resectable. Aim is … Continue reading Living Longer: Early Stage/ Resectable Pancreatic Cancer